Skip to main content
Premium Trial:

Request an Annual Quote

NIMH Pledges $2M to Study Depression Pharmacogenomics

NEW YORK (GenomeWeb News) — The National Institute of Mental Health plans to grant around $2 million to investigators who are studying ways to apply pharmacogenomics and personalized medicine technologies and techniques to the treatment of depression, the National Institutes of Health announced last week.
 
The goal of the project, which will support around seven researchers for up to three years, is to test new approaches and to develop models that will integrate specific patient characteristics into the treatment of depression.
 
NIMH said in a request for applications that the research can focus on, but is not limited to, analyzing databases for predicting treatment responses; identifying patients most likely to benefit from specific treatments; using pharmacogenomics studies to identify predictors of safety; matching patient types with treatment types; studying cost vs. benefit analysis of treatments; and developing statistical methods related to personalized treatment of depression.
 
Applications are due on June 20. More information can be found here.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.